By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Janssen Pharmaceutical Inc.  

1125 Trenton-Harbourton Road

Titusville  New Jersey  08560  U.S.A.
Phone: 609-730-2000 Fax: n/a



Company News
Janssen Pharmaceutical Release: U.S. FDA Approves INVOKAMET XR (Canagliflozin / Metformin Hydrochloride Extended-Release) For The Treatment Of Adults With Type 2 Diabetes 9/21/2016 8:18:00 AM
Janssen Pharmaceutical Announces 25 Presentations At Upcoming European Society of Cardiology Congress 2016, Including New Clinical And Real-World Research On XARELTO And Latest Findings From REVISIT-US 8/22/2016 8:44:28 AM
Achillion (ACHN) Announces Upcoming Presentation Of Interim Phase IIa Results From The Janssen Pharmaceutical Sponsored Trial Of Odalasvir, AL-335 And Simeprevir At The European Association For The Study Of The Liver (EASL) Special Conference 8/11/2016 10:54:21 AM
Janssen Pharmaceutical Presents New Data Showing Invokana (Canagliflozin) Is Associated With Greater Blood Glucose Control And Treatment Adherence Compared To Dpp-4 Inhibitors 6/13/2016 11:17:17 AM
ASCO2016: Janssen Pharmaceutical Release: Daratumumab (DARZALEX) Combination Therapy Significantly Extended Progression-Free Survival In Previously Treated Patients With Multiple Myeloma 6/6/2016 1:14:01 PM
Janssen Pharmaceutical Release: U.S. FDA Expands Indication of INVOKAMET (Canagliflozin/Metformin Hcl) To Include First-Line Treatment Of Adults With Type 2 Diabetes 5/24/2016 6:36:01 AM
Cue Announces Collaboration With Johnson & Johnson (JNJ) And Johnson & Johnson Innovation (JNJ) To Accelerate Development Of Quantitative HIV Viral Load Test For Resource Poor Settings 2/4/2016 11:15:59 AM
ChemDiv, Inc. Announces Achievement Of A Development Milestone In A Drug Discovery Collaboration With Janssen Pharmaceutical 1/12/2016 12:40:50 PM
Evotec AG (EVTG.F) Achieves Important Milestone In TargetAD Collaboration With Janssen Pharmaceutical In Alzheimer's Disease 1/12/2016 12:10:54 PM
Janssen Pharmaceutical, Medivir (MVRBF) Terminate AL-704 Phase I for Treatment of Hepatitis C 12/21/2015 6:24:41 AM